Redeye updates its estimates following Surgical Science’s Q4 2022 report, which broadly aligned with...
Lucky Games har publicerat bolagets delårsrapport för fjärde kvartalet 2022 och är redo för ytterlig...
Safe Lane Gaming publicerade den 23 februari år 2022 bolagets delårsrapport för fjärde kvartalet 202...
Redeye updates its Imint estimates and discusses the bleak smartphone volumes and the company’s 2025...
Rapportkommentar Egetis släppte under onsdagen sin rapport för det fjärde kvartalet.
Waystream avslutar året exemplariskt och växer rörelseresultat i Q4 med hela 97 procent.
Investmentbolaget Archelon investerar främst i prospekteringsbolag inom gruvnäring, men innehar även...
Dovre announced preliminary Q4 figures already on Feb 3, and therefore the Q4 report didn’t hold man...
Redeye provides a first comment on the back of Northbaze Group’s Q4 report.
Performing in-depth analysis of mesdopetam's Ph 2b with Ipsen Other assets advancing; pirepemat Ph 2...
Temenos' SaaS sales grew 32% in 2022 Earlier this week, Formpipe's banking platform partner, Temenos...
Strong organic growth continues Cash flow better than we expected '23e EV/EBITA ~8x Q4 report Due t...
Devyser lämnar ett starkt helår bakom sig och står välrustade inför ett högintressant 2023.
Q4: 4% sales growth y-o-y, but EBITA almost halved PION Group reported Q4 sales of SEK 532m (512m), ...
Redeye concludes that Q4 was stronger than expected, both on revenues and much above on EBIT.
Redeye will likely raise its Base Case and forecasts following a strong Q4, in line with the prelimi...
Redeye provides an update on Thunderful Group following its Q4 2022 report which was released on Feb...
Redeye comments on W5’s Q4-results where revenue came in stronger than expected while profit was bel...
Calliditas recorded Q4 Tarpeyo sales of SEK 169m which is slightly below our and the markets expecta...
ARR was EUR18.4m in Q4 2022, growing 19% YoY and 4.
